Green Tea for Health & Longevity - Quick Reference Sheet

Green Tea for Health & Longevity

Created on 07/01/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

Brewed green tea offers modest, dependable improvements in cholesterol, blood sugar, blood pressure, and body weight, with population data linking regular drinking to lower heart-disease and overall death rates. Brewed tea is safe long-term; concentrated extract capsules taken in large single doses on an empty stomach can cause liver injury. (Full Review)

Protocol

Standard intake (brewed tea)
3–5 cups daily
Delivering several hundred mg catechins, consumed across the day
Standard supplementation (extract)
250–400 mg EGCG/day
Standardized extract taken with food, ideally in divided doses
Timing & dosing
Earlier in day, split doses
Splitting the daily dose with meals maintains exposure and lowers peak EGCG linked to liver injury
Time to effect
Cardiometabolic markers
4–12 weeks
Lipids, blood sugar, blood pressure changes emerge with consistent intake
Alertness
Within an hour
Acute caffeine/L-theanine effects on alertness

Benefits

Contraindications
  • Active liver disease or prior supplement-related liver injury (avoid concentrated extracts)
  • Pregnancy and breastfeeding (avoid high-dose extracts, limit caffeine)
  • Significant iron-deficiency anemia, poorly controlled arrhythmias, or anxiety disorders (limit caffeine-bearing forms)
Key Interactions
  • Anticoagulant and antiplatelet drugs (warfarin, aspirin, clopidogrel)
  • Stimulant medications and other caffeine sources (ephedrine, decongestants, ADHD medications)
  • Iron supplements
  • Hepatotoxic drugs and supplements (high-dose acetaminophen, certain statins, other herbal extracts)
  • Beta-blockers and certain blood-pressure drugs
  • Bortezomib and certain chemotherapies

Risk & Side Effects

  • High: Liver injury from concentrated extracts; caffeine-related effects
  • Medium: Reduced iron absorption; gastrointestinal upset
  • Low: Bleeding and drug-interaction risk
  • Speculative: Fluoride and heavy-metal accumulation

Monitoring

Marker Target Why
ALT < 25 U/L (men), < 20 U/L (women) Detects early liver injury from extracts
AST < 25 U/L Complements ALT for liver-injury detection
LDL cholesterol < 100 mg/dL Tracks the main lipid benefit
Fasting glucose 70–90 mg/dL Tracks glycemic benefit
HbA1c < 5.4% Captures longer-term glucose effect
Blood pressure < 120/80 mmHg Tracks the blood-pressure benefit
Ferritin 50–150 ng/mL Screens for iron depletion from catechins

Cadence: Liver enzymes at baseline, 8–12 weeks, then every 6–12 months; cardiometabolic markers reassessed at 12 weeks and periodically thereafter

Qualitative Assessment

  • Sleep quality and ease of falling asleep (sensitive to caffeine timing)
  • Daytime energy and alertness without jitteriness
  • Cognitive focus and subjective calmness ("calm alertness")
  • Digestive comfort (absence of nausea or reflux)
  • Absence of liver-warning symptoms (fatigue, dark urine, right-upper-abdominal discomfort)